Publication:
How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?

Simple item page
dc.contributor.authorLekovic, Danijela (36659562000)
dc.contributor.authorMiljic, Predrag (6604038486)
dc.contributor.authorDmitrovic, Aleksandar (56341041400)
dc.contributor.authorThachil, Jecko (23029666900)
dc.date.accessioned2025-06-12T17:26:27Z
dc.date.available2025-06-12T17:26:27Z
dc.date.issued2017
dc.description.abstractWomen are increasingly encouraged to participate in making decisions about hormone replacement therapy (HRT). In postmenopausal women with severe vasomotor symptoms, HRT can significantly improve the quality of life. However, the use of HRT may also increase the risk of venous thromboembolism (VTE), the risk which depends of both treatment-related and patient-related factors. This review summarizes some important points about the selection of the safest hormonal replacement modality in women with a history of VTE and management of VTE risks in postmenopausal women wishing to take HRT. © 2016 Elsevier Ltd
dc.identifier.urihttps://doi.org/10.1016/j.blre.2016.12.001
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85008177583&doi=10.1016%2fj.blre.2016.12.001&partnerID=40&md5=adbeceb9072d417b4a85fba5c1dcbca0
dc.identifier.urihttps://remedy.med.bg.ac.rs/handle/123456789/6969
dc.subjectHormone replacement therapy
dc.subjectMenopause
dc.subjectVenous thromboembolism
dc.titleHow do you decide on hormone replacement therapy in women with risk of venous thromboembolism?
dspace.entity.typePublication

Files

Collections

Publikacije / Publications